At Holloway Summit, FTD Imaging Shows New Vista
PET tracers for the two main proteopathies of FTD, tau and TDP-43, are now in trials, while AI-enabled analysis of FDG-PET scans discriminates between diseases.
ALL NEWS
204 RESULTS
Sort By:
- Most Recent
- Most Commented
Second Holloway Summit Showcases Intense Search for FTD Biomarkers
Scientists have identified potential fluid and imaging markers that could discriminate between the two main proteopathies of FTD, tau and TDP-43.
Holloway Summit 2023: FTD Biomarkers
Second Holloway Summit Showcases Intense Search for FTD Biomarkers At Holloway Summit, FTD Imaging Shows New Vista To enable clinical trials in frontotemporal dementia, scientists need biomarkers that distinguish its several underlying pathologies. At a r
APOE Christchurch Variant Tames Tangles and Gliosis in Mice
Whether expressing two copies of APOE3 or -E4 with this variant, mice had less tauopathy, gliosis, atrophy. One copy of Christchurch partially protected.
Polygenic Scores Point to Microglia, Astrocytes in Alzheimer's Pathogenesis
Cell-type-specific polygenic risk scores single out microglia as influencers of Aβ and tau pathology, as well as cognitive decline.
Can Organ Aging Clock Foretell Cognitive Decline?
Proteins in human blood flag organ-specific accelerated aging and disease risk. For cognition, 49 proteins better predicted decline then did plasma p-tau 181.
Sought FUS, Found TAF—A New Fibril in Frontotemporal Dementia
Cryo-EM identified TAF15 filaments at the heart of protein aggregates in some FTD cases. Should FDT-FUS be renamed FTD-FET?
Are T Cells to Blame for Cognitive Impairment Caused by Hypertension?
In the dura, these lymphocytes release interleukin 17, activating perivascular macrophages. They curb cerebral blood flow, and mice become forgetful.
Transient Filament Yields AD and CTE Tau Fibrils
Cryo-EM reveals a common conformational progenitor for tau filaments found in Alzheimer’s disease and chronic traumatic encephalopathy.
And Then There Were Five: CSF Proteomics Defines Alzheimer’s Subtypes
Each associates with distinct AD risk variants, brain atrophy, and disease severity.
Two New p-Tau217 Blood Tests Join a Crowded Field
C2N’s PrecivityAD2 and ALZpath Inc.’s p-tau217 immunoassay identify people with AD with good accuracy.
Plasma p-Tau-217 Assays Work Well, But No Home Run for Diagnosis
For a diagnostic test, specificity and sensitivity fall a little shy. Using two cut points might solve the problem.
Can a Fatty Acid Explain Sex Differences in Parkinson’s?
Adding palmitate makes an estrogen receptor linger at the synapse, curbing α-synuclein aggregation, motor deficits, and faulty memory. In mice.
New Alzheimer’s Diagnostic Criteria Remain ‘Research Only’
This clarification comes after geriatricians argued that diagnosing AD in people without symptoms is premature, and the NIH pulled its name.
Do APOE4’s Lipid Shenanigans Trigger Tauopathy?
Faulty lipid metabolism is being blamed for supercharging tau phosphorylation. Restoring lipid efflux protects the mouse brain.
Current Filters
- Date Range : May 2023 to May 2024 x